U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528495) titled 'A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's' on Dec. 06, 2022.
Brief Summary: The present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.
Study Start Date: April 03, 2024
Study Type: INTERVENTIONAL
Condition:
Head and Neck Cancer
Intervention:
RADIATION: IMRT - adjuvant concurrent CRT/ RT
IMRT - adjuvant concurrent CRT/ RT as 66Gy/60 Gy in 33/30 fractions to primary and regional lymphatics
RADIATION: ommission of IMRT - adjuvant concu...